Cargando…
Metabolomics combined with clinical analysis explores metabolic changes and potential serum metabolite biomarkers of antineutrophil cytoplasmic antibody-associated vasculitis with renal impairment
BACKGROUND: Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is an autoimmune systemic disease, and the majority of AAV patients have renal involvement presenting as rapid progressive glomerulonephritis (GN). Currently, the clinically available AAV markers are limited, and some...
Autores principales: | Liu, Siyang, Xu, Qing, Wang, Yiru, Lv, Yongman, Liu, Qing quan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024486/ https://www.ncbi.nlm.nih.gov/pubmed/36942002 http://dx.doi.org/10.7717/peerj.15051 |
Ejemplares similares
-
Identification of potential biomarkers and therapeutic targets for antineutrophil cytoplasmic antibody-associated glomerulonephritis
por: Wang, Yiru, et al.
Publicado: (2023) -
Animal models for anti‐neutrophil cytoplasmic antibody‐associated vasculitis: Are current models good enough?
por: Huang, Fei, et al.
Publicado: (2023) -
Isolated Antineutrophil Cytoplasmic Antibody-Associated Coronary Vasculitis and Valvulitis
por: Kim, Yoon Kook, et al.
Publicado: (2021) -
Serum interleukin-16 significantly correlates with the Vasculitis Damage Index in antineutrophil cytoplasmic antibody-associated vasculitis
por: Yoon, Taejun, et al.
Publicado: (2020) -
Antineutrophilic Cytoplasmic Antibody Positive Vasculitis
Associated with Methimazole Use
por: Shikha, Deep, et al.
Publicado: (2015)